Daniel Stauder
Stock Analyst at Citizens Capital Markets
(0.25)
# 2368
Out of 5,319 analysts
15
Total ratings
30.77%
Success rate
-3.84%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ATRC AtriCure | Reiterates: Market Outperform | 60 60 | 32.01 | 87.44% | 5 | Apr 2, 2025 | |
STIM Neuronetics | Maintains: Market Outperform | 3 7 | 3.76 | 86.17% | 1 | Mar 5, 2025 | |
LMAT LeMaitre Vascular | Maintains: Strong Buy | 105 110 | 86.28 | 27.49% | 4 | Feb 28, 2025 | |
AXON Axon Enterprise | Reiterates: Market Outperform | 725 725 | 559.53 | 29.57% | 1 | Feb 26, 2025 | |
AORT Artivion | Reiterates: Market Outperform | 33 33 | 22.93 | 43.92% | 3 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | May 7, 2024 |